The ESSENCE of hope: what semaglutide's Food and Drug Administration approval means for metabolic dysfunction-associated steatohepatitis [0.03%]
希望的实质：GLP-1激动剂索马鲁肽获批治疗非酒精性脂肪肝的意义
Mariam Alamgir,Aalam Sohal,Kris V Kowdley
Mariam Alamgir
Hybrid hepatic artery debranching for pancreatic cancer with celiac axis occlusion [0.03%]
腹腔干闭塞伴发胰腺癌的肝动脉杂交去分支化手术
Artur Rebelo,Johannes Klose,Jumber Partsakhashvili et al.
Artur Rebelo et al.
Does a patient who needs portal vein embolization (PVE) to proceed to major hepatectomy (MH) have the same hepatic functional reserve than a patient with no preoperative PVE? [0.03%]
需要门静脉栓塞以进行较大肝切除的患者与不需要术前门静脉栓塞的患者肝功能储备相同吗？
Stéphanie Truant,Clio Baillet,Mehdi El Amrani et al.
Stéphanie Truant et al.
Background: While remnant liver function (RLF) gain after portal vein embolization (PVE) was reportedly higher than volume gain, some patients apparently fit for surgery develop post-hepatectomy liver failure (PHLF). This...
Perioperative antibiotic prophylaxis in pancreatoduodenectomy: toward a new standard, but questions remain [0.03%]
胰十二指肠切除术的围手术期抗生素预防：新的标准？但仍存疑问
Zachary A Whitham,Adam C Yopp
Zachary A Whitham
Advancing the enhanced recovery after surgery paradigm in liver transplantation: evidence-based strategies for a comprehensive care continuum [0.03%]
肝移植术后加速康复方案的实施：围手术期循证策略促进患者全面快速康复
Dipesh Kumar Yadav,Yisheng Zhang,Yiren Hu
Dipesh Kumar Yadav
A rare case of giant paraganglioma in the first porta hepatis area associated with neurofibromatosis type 1 [0.03%]
与I型神经纤维瘤病相关的第一肝门巨大副神经节瘤罕见病例报告
Xuming Zhang,Junqing Xie,Xianhui Lin et al.
Xuming Zhang et al.
Phase II trial of hepatic arterial infusion chemotherapy plus bevacizumab and toripalimab for advanced biliary tract cancers: efficacy, safety, and exploratory analysis [0.03%]
肝动脉灌注化疗序贯贝伐珠单抗和特瑞普利单抗治疗晚期胆道肿瘤患者Ⅱ期临床研究：疗效、安全性及探索性分析
Kanglian Zheng,Shijie Fu,Xu Zhu et al.
Kanglian Zheng et al.
Background: Chemotherapy combined with immune checkpoint inhibitor have prolonged survival of patients with advanced biliary tract cancers (BTCs), and the previous studies showed the synergistic anti-tumor effect of chemo...
Evolution of two-stage hepatectomy: 25 years of modifications and lessons learned [0.03%]
两期肝切除术的演变：25年来的改良和经验教训
Zenichi Morise
Zenichi Morise
Factors associated with textbook outcome after robotic-assisted pancreatoduodenectomy: a single surgeon's retrospective cohort [0.03%]
机器人辅助胰十二指肠切除术后保留幽门的胃窦代胰肠吻合影响因素分析：单中心回顾性队列研究
Ai-Qing Fu,Xi-Tai Huang,Jian-Peng Cai et al.
Ai-Qing Fu et al.
Background: Textbook outcome (TO) represents as an important parameter in assessing the quality of surgical procedures. The factors that contributed to the achievement of the TO in robotic-assisted pancreaticoduodenectomy...
Remote robot-assisted pancreatoduodenectomy for one patient with pancreatic ductal adenocarcinoma [0.03%]
一例胰腺导管腺癌患者的远程机器人辅助胰十二指肠切除术
Chen-Song Huang,Yuan-Yuan Chen,Xi-Tai Huang et al.
Chen-Song Huang et al.